These subtypes of BC may have different phenotypes because of the downregulation of CALM2, a calcium‐binding protein involved in cell cycle development, apoptosis, and proliferation [138], which occurs as a result of bc200 overexpression. The gene discussed is BCYRN1; the disease is breast cancer.